
Capiton buys majority stake in Kutterer Mauer

Capiton has acquired a majority stake in tube and jar cap and closure manufacturer Kutterer Mauer.
Klaus Mauer and members of the management team are investing alongside Capiton.
The GP is deploying equity via Capiton VI, which has a EUR 550m target and is expected to reach a final close shortly, as reported.
In addition to its equity investment, Capiton said in a statement that additional funds have been reserved for organic and inorganic growth initiatives. The GP intends to support the company in its development of its product portfolio and geographical presence.
Kutterer Mauer will be the sixth platform deal from the fund, which made its first deal in July 2020, acquiring generic pharmaceuticals producer MIP Pharma (formerly CNP Group).
The deal announcement comes one month after Capiton raised a top-up single asset fund for KD Pharma in July 2021, as reported.
Company
Kutterer Mauer AG was formed in July 2008 via the merger of Kutterer Kunststofftechnik and Mauer. The company produces cap and closure fastenings for the cosmetics, food and pharmaceutical industries. Its products include flip tops, caps for aluminium, plastic or laminate tubes, as well as nozzles and closures for jars.
The company generated revenues of EUR 81.6m and EBITDA of EUR 10.4m in the 2019/20 financial year, versus turnover of EUR 74.7m and EBITDA of EUR 6.3m in the previous year, according to its latest publicly available accounts. Kutterer Mauer is headquartered in Karlsruhe and has six manufacturing sites in Germany, Austria, Poland and the US and employs more than 450 staff.
People
Kutterer Mauer – Susanne Kutterer-Schacht, Klaus Mauer (board chairmen).
Capiton – Roumyana Schnettler (partner); Frank-Markus Winkler (managing partner); Alexander Graat (investment director); Martin Gwashavanhu (analyst).
Advisers
Equity – RSM (financial due diligence); EY (tax); Clifford Chance (legal); Lupp & Partner (legal); Allen & Overy (legal); Roland Berger (commercial due diligence); KPMG (debt advisory); Willis Towers Watson (insurance); ERM (environmental due diligence); Tauw (ESG due diligence).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater